Sihuan Pharm
aceutical manufacture and sale of pharmaceutical products such as cardio-cerebral vascular and anti-infective drugs... Read moreSihuan Pharm
aceutical manufacture and sale of pharmaceutical products such as cardio-cerebral vascular and anti-infective drugs... Read more
News
Aug 21, 2024
FinanzNachrichten
Sihuan Pharm: EQS Newswire: Sihuan Pharmaceutical Holdings Group: Sihuan Pharmaceutical (00460.HK): Subsidiary Huisheng Biopharmaceutical Reshapes Diabetes Treatment Landscape With Two Home-Grown Insulin Products
Aug 12, 2024
FinanzNachrichten
Sihuan Pharm: EQS Newswire: Sihuan Pharmaceutical Holdings Group: Chinese Self-Developed IDegAsp Debuts! Huisheng Pharm Strives To Be Diabetes Drug Bellwether With Blockbuster Drugs in Going Global
Mar 28, 2024
Marketscreener
Sihuan Pharm: Sihuan Pharmaceutical Holdings Group Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Feb 27, 2024
Pharamceutical Technology
Sihuan Pharm: Sihuan Pharmaceutical Holdings Group sees highest patent filings and grants during October in Q4 2023
Dec 21, 2023
Pharamceutical Technology
Sihuan Pharm: Birociclib by Sihuan Pharmaceutical Holdings Group for Solid Tumor: Likelihood of Approval
Oct 13, 2023
Business News Asia
Sihuan Pharm: Sihuan Pharmaceutical Was Selected As One Of The First Echelon Of Enterprises In The list of China's Top 100 Pharmaceutical Innovative Enterprises in 2023
Jul 03, 2023
Marketscreener
Sihuan Pharm: Sihuan Pharmaceutical Holdings Group Ltd. Announces Approval of Phase II Clinical Trial Application of Birociclib by the Center for Drug Evaluation of the National Medical Products Administration of the People's Republic of China
Jun 08, 2023
StreetInsider
Press Release: Sihuan Pharm : Xuanzhu Biopharm, a subsidiary of Sihuan Pharmaceutical, progresses at full speed in innovative research and development Presents major research results of birociclib, the start product, at the intern
Jan 04, 2023
BioSpace
Sihuan Pharm: Sihuan Pharmaceutical0460.HK: Huisheng Biopharmaceutical Successfully Completed the A + Round of Financing
Jun 02, 2022
ChinaBio Today
Sihuan Pharm: Sihuan and CTTQ-Akeso Team up to Test AXL Inhibitor and PD-1 in Solid Tumors
Sihuan Pharm Competitors
1
2
3
4
5
6
7
8
9
10